Teladoc Health Inc
NYSE:TDOC
Teladoc Health Inc
NYSE:TDOC
Price:
13.01 USD
-2.4%
Market Closed
Updated:
Apr 28, 2024
Teladoc Health Inc
Research & Development
|
Teladoc Health Inc
Research & Development Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
GDRX
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Teladoc Health Inc
NYSE:TDOC
|
Research & Development
-$342.9m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$629m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-37%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$116.5m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$80.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Research & Development
-$135.8m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
See Also
What is Teladoc Health Inc's Research & Development?
Research & Development
-342.9m
USD
-342.9m
USD
Based on the financial report for Mar 31, 2024, Teladoc Health Inc's Research & Development amounts to -342.9m USD.
What is Teladoc Health Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-43%
-43%
Over the last year, the Research & Development growth was -3%. The average annual Research & Development growth rates for Teladoc Health Inc have been -15% over the past three years , -43% over the past five years .
You don't have any saved screeners yet
